The Data on AI

Gilead AI Profile

USA Flag Foster City, CA
AI Readiness Score:   13.24

No. 385 Out Of All Companies Ranked

12 out of 21 in Healthcare and other selected competitors
Total Employees   17,600
Market Cap   $130.75 billion
CEO   Mr. Daniel P. O'Day
Exchange   NASDAQ
AI AND DATA STORIES

Our estimates on data scientist numbers for Gilead trace back to several sources that we check on a monthly basis, including the company's website, career boards and other methods.

The number of data scientists a company has is important because it reflects its capability to innovate, scale AI initiatives, and leverage data-driven decision-making to maintain a competitive edge in AI development and application.

Gilead's Public AI Posture

AI Mentions in Quarterly Earnings Calls (2017-Q3 to 2022-Q3): 0.11

AI Mentions in Quarterly Earnings Calls (2022-Q4 to current): 0.11

Post ChatGPT Release, AI Mentions Moved 0.02 Standard Deviations

Posture: Laggard

Gilead holds 0 patents focused on AI subjects. We have combed through the records of the United States Patent Office for filings related to AI for more than 500 companies. We consider a qualifying patent to be one that primarily concerns artificial intelligence or machine learning. Patents that simply mention these things do not figure in our count.

Examining CapEx shows how much Gilead invests in physical assets, highlighting its commitment to growth and the infrastructure needed to support AI initiatives.

This graph provides a comprehensive view of Gilead's strategic allocation of resources by comparing free cash flow, R&D costs, and CapEx over time, highlighting how investments in AI and innovation are balanced against financial health and infrastructure commitments. It offers insights into whether a company is sustainably prioritizing AI development amidst its broader financial strategies.